MedTrace Logo

Retinal Function in Relation to Long Term Changes in the Glucose Level

NCT00973401 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2009-09-24

No results posted yet for this study

Summary

The purpose of this study is to measure the amplitude and implicit time of electroretinogram (ERG), darkadaptation and the calibre of retinal vessels before and after optimized medical treatment of diabetic individuals (a lower blood glucose level) over a period of 12 months. Newly diagnosed type 1 and type 2 diabetics as well as dysregulated type 1 and type 2 diabetic individuals will be included. Retinal vessel calibre measurements will be used as an estimation of changes in the retinal perfusion.

Conditions

Interventions

OTHER

Insulin pump

Patients receive an insulin pump that optimizes their glucose control.

Sponsors & Collaborators

  • Glostrup University Hospital, Copenhagen

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00973401 on ClinicalTrials.gov